Skip to main content

What Illumina's Quarter ended Sep 27, 2026 10-Q says: 3 signals

Illumina filed its latest 10-Q with the SEC on Oct 30, 2026. It discusses debt refinancing, general counsel change and software implementation.

Public (ILMN)Biotechnology Research10,000+ employeesillumina.comLinkedIn

Get Illumina's live signals in Claude or ChatGPT, or by API

AskWhat changed at Illumina this week? Use Autobound signals for illumina.com.
Filed
Oct 30, 2026
Period
Quarter ended Sep 27, 2026
Filings
3
Signals
8

Source: Autobound Signal API · 107 signals tracked for Illumina · updated

10-Q · latest 8

What Illumina's 10-Q filings say

  1. 10-Q · Quarter ended Sep 27, 2026

    Filed · 3 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 28, 2026

    Filed · 3 signals

    SEC EDGAR
  3. 10-Q · Quarter ended Mar 29, 2026

    Filed · 2 signals

    SEC EDGAR

Earnings calls

Illumina earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Q3 revenue $1.17B up 4.7% rest of world organicIllumina reported Q3 2026 revenue of $1.17 billion, reflecting a 4.7% YoY organic growth in Rest of World markets (5% organic overall), driven by NovaSeq X adoption. Sequencing consumables reached $792M (+5% organic RoW), while non-GAAP operating margin expanded 100 bps above guidance to 25.0% and diluted EPS grew 7% to $1.44.
FY2026 revenue guidance raised by $30M to $4.65BFull-year 2026 revenue guidance was increased by $30 million at the midpoint to a range of $4.64 billion to $4.66 billion, backed by Q3 outperformance and expanding NovaSeq X consumables demand. Operating margin targets were raised to approximately 23.6% and diluted EPS guidance was increased to $5.40-$5.45 (+12% to 13% YoY growth).
Partnership with GSK expands consortium for Billion Cell AtlasGSK joined Illumina's consortium to leverage functional single-cell genomics data for target validation and drug discovery. The initiative is expanding from 1 billion to 5 billion cells, creating revenue opportunities in multi-omics and AI training datasets.
Commercializing BioInsight platform uniting AI models and multi-omicsIllumina launched BioInsight ecosystem and software platform bringing together multi-omics assays, curated data, and AI models such as SpliceAI2. The offering aims to drive 1% to 2% incremental top-line growth starting in 2027.
Managing Unreliable Entity List scrutiny and trade restrictionsIllumina is actively navigating regulatory hurdles in China, including the Unreliable Entity List and emerging US export restrictions on Chinese competitors. Despite returning to organic growth in the region in Q3, geopolitical and regulatory overhang persists.
Electronic component pricing and shipping costs driving headwindsManagement cited significant cost inflation from electronic components, shipping freight, and tariffs during 2026. Despite these headwinds, disciplined investment and operational execution enabled operating margins to expand by 400 basis points over 2024 levels.

Signal API · MCP

Track Illumina with the Signal API

One POST /v1/companies/enrich call with illumina.com returns Illumina 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"illumina.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Illumina 10-Q

When did Illumina file its latest 10-Q?
Illumina filed its latest 10-Q (Quarter ended Sep 27, 2026) on Oct 30, 2026. The one before it was filed on Jul 31, 2026.
What did Illumina disclose in its latest 10-Q?
From the filing dated Oct 30, 2026: Illumina issued $300 million of 2029 Term Notes and entered a $1 billion credit facility
What did Illumina say on its recent earnings calls?
Q3 FY2026: Q3 revenue $1.17B up 4.7% rest of world organic (dated Oct 29, 2026).
Where can I read Illumina's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000207/ilmn-20260927.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →